Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma - Quiz - MDSpire

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma

  • By

  • Zijuan Liu

  • Yating Yan

  • Caihong Jiang

  • June 16, 2026

  • 0 min

Share

Original Source(s)

Related Content